JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4401
Global Water Resources
GWRS
$230M
| $615K | ﹤0.01% |
36,005
-16,337
| -31% | -$277K |
2017 Q4
14 quarters
|
|
|
DMTK
4402
DELISTED
DermTech, Inc. Common Stock
DMTK
| $614K | ﹤0.01% |
14,790
+10,889
| +279% | +$447K |
2020 Q2
4 quarters
|
|
|
CBIO
4403
Crescent Biopharma
CBIO
$530M
| $612K | ﹤0.01% |
2,639
+117
| +5% | +$29.8K |
2018 Q2
12 quarters
|
|
|
CHS
4404
DELISTED
Chicos FAS, Inc.
CHS
| $611K | ﹤0.01% |
92,932
-201,763
| -68% | -$869K |
2013 Q2
32 quarters
|
|
4405
Spyre Therapeutics
SYRE
$7.93B
| $610K | ﹤0.01% |
3,505
+2,345
| +202% | +$426K |
2017 Q2
16 quarters
|
|
|
CERE
4406
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $610K | ﹤0.01% |
23,799
+21,164
| +803% | +$303K |
2021 Q1
1 quarter
|
|
4407
Coastal Financial
CCB
$620M
| $608K | ﹤0.01% |
21,268
-6,777
| -24% | -$198K |
2018 Q3
11 quarters
|
|
4408
Sasol
SSL
$8.95B
| $608K | ﹤0.01% |
39,665
+27,139
| +217% | +$443K |
2020 Q4
2 quarters
|
|
4409
Teucrium Corn Fund
CORN
$138M
| $607K | ﹤0.01% |
28,416
+21,773
| +328% | +$439K |
2016 Q2
20 quarters
|
|
4410
Momentus
MNTS
$82.6M
| $606K | ﹤0.01% |
3
| – | – |
2021 Q1
1 quarter
|
|
4411
Invesco Financial Preferred ETF
PGF
$616M
| $605K | ﹤0.01% |
31,395
-6,920
| -18% | -$132K |
2014 Q1
29 quarters
|
|
|
FRG
4412
DELISTED
Franchise Group, Inc.
FRG
| $605K | ﹤0.01% |
17,156
-19,451
| -53% | -$716K |
2020 Q2
4 quarters
|
|
4413
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$421M
| $604K | ﹤0.01% |
18,750
+1,945
| +12% | +$63.1K |
2020 Q4
2 quarters
|
|
4414
ProShares Short 20+ Year Treasury ETF
TBF
$143M
| $603K | ﹤0.01% |
35,700
+27,204
| +320% | +$477K |
2021 Q1
1 quarter
|
|
4415
Turning Point Brands
TPB
$1.11B
| $602K | ﹤0.01% |
13,156
-5,246
| -29% | -$243K |
2017 Q4
14 quarters
|
|
|
BEDU
4416
DELISTED
Bright Scholar Education Holdings
BEDU
| $601K | ﹤0.01% |
35,413
-399
| -1% | -$7.68K |
2018 Q3
11 quarters
|
|
4417
MasterCraft Boat Holdings
MCFT
$483M
| $601K | ﹤0.01% |
22,865
-30,171
| -57% | -$843K |
2017 Q4
14 quarters
|
|
|
NH
4418
DELISTED
NantHealth, Inc
NH
| $599K | ﹤0.01% |
17,179
-90
| -0.5% | -$3.58K |
2020 Q1
5 quarters
|
|
4419
CALL
Green Plains
GPRE
$1.05B
| $598K | ﹤0.01% |
17,800
| – | – |
2020 Q4
2 quarters
|
|
4420
Atea Pharmaceuticals
AVIR
$409M
| $596K | ﹤0.01% |
27,707
+19,509
| +238% | +$586K |
2020 Q4
2 quarters
|
|
4421
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.81B
| $594K | ﹤0.01% |
6,992
+1,236
| +21% | +$100K |
2018 Q4
10 quarters
|
|
4422
Norwood Financial Corp
NWFL
$362M
| $592K | ﹤0.01% |
22,753
-17,104
| -43% | -$437K |
2017 Q4
14 quarters
|
|
4423
Goldgroup Mining
GORO
$539M
| $591K | ﹤0.01% |
57,315
-8,286
| -13% | -$91.8K |
2016 Q4
18 quarters
|
|
4424
iShares US Utilities ETF
IDU
$1.33B
| $591K | ﹤0.01% |
7,530
+88
| +1% | +$7.14K |
2013 Q2
32 quarters
|
|
4425
Cytokinetics
CYTK
$9.12B
| $589K | ﹤0.01% |
29,799
+4,778
| +19% | +$112K |
2017 Q4
14 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.